RESERVA LA FECHA ‼32 Grupo Español de Tratamiento de Tumores Digestivos International Symposium 📅11-13 Dic. 2024 Pamplona 🗣️Punto de encuentro donde especialistas nacionales e internacionales presentarán los últimos avances en investigación y tratamiento de tumores digestivos  #SomosTTD  ttdgroup.org/formacion/simp…

🚨Awaited prospective data for neoadjuvant in PNETs BJS Single arm preop PRRT for high-risk PNET 👥31 patients ✔️59% response rate ✔️path response exists 36% fibrosis ✔️M&M profile not altered Important step forward - congrats Stefano Partelli! 📝👇🏻

Enhorabuena Grupo GETNE 🥰

Clinical Outcomes and Histologic Findings of pts With HCC With Durable Partial Response or Durable Stable Disease After Atezolizumab + Bevacizumab Journal of Clinical Oncology doi.org/10.1200/JCO.24… 🔎Imbrave150 & RWD 👉favorable PFS & OS + high rates of pCR in pts w/ PR for ≥6 mo ESMO - Eur. Oncology

Bispecific antibodies: advancing precision oncology Trends in Cancer doi.org/10.1016/j.trec… 👉Bispecific antibodies are on the rise with promising data 👏Excellent in depth review ESMO - Eur. Oncology

BRAF + EGFR +/- MEK inhibitors after ICI in BRAF V600E mutated & MSI CRC European Journal of Cancer doi.org/10.1016/j.ejca… 👉Lower ORR & DCR, but similar PFS & OS compared to pMMR/MSS BRAFm CRC 🧐Intersting question & reassuring data ESMO - Eur. Oncology

📢Hepatopancreaticobiliary-NET abstracts in #ESMO24 ESMO - Eur. Oncology ➡️HCC ✅LBA3 - Transarterial Chemoembolization (TACE) With or Without Lenvatinib (len) + Pembrolizumab (pembro) for Intermediate-Stage Hepatocellular Carcinoma (HCC): Phase 3 LEAP-012 Study ✅LBA38 - Iparomlimab and

Trastuzumab deruxtecan in HER2+ advanced mCRC The Lancet Oncology doi.org/10.1016/S1470-… 🔎DESTINY-CRC02 phs 2, 122 pts 👉5·4 & 6·4 mg/kg 👉ORR 37·8% & 27·5% 👉mPFS 5·8 & 5·5 mo 👉mOS 13·4 mo & NE 🧐support approval for pts with HER2-positive solid tumours ESMO - Eur. Oncology

📢Gastroesophageal cancer abstracts in #ESMO24 ESMO - Eur. Oncology ✅LBA58 - A randomized phase III trial of perioperative chemotherapy (periop CT) with or without preoperative chemoradiotherapy (preop CRT) for resectable gastric cancer (AGITG TOPGEAR): final results from an intergroup

📢Colorectal cancer abstracts in #ESMO24 ESMO - Eur. Oncology ✅515MO - Encorafenib + cetuximab (EC) + FOLFIRI for BRAF V600E-mutant metastatic colorectal cancer (mCRC): Updated results from the BREAKWATER safety lead-in (SLI) ✅516MO - Zanidatamab (Zani) + chemotherapy (CT) in first-line

📌Aula Virtual TTD en Tumores Digestivos Ya han pasado 262 alumnos 🎯Formación específica con toda la evidencia científica disponible actualizada en estas patologías 💻modalidad e-learning ✅En marcha 3ª Edición ℹ Más info: aulavirtualttd.es #SomosTTD

📍 ¿Conoces la trayectoria del TTD? ✅17.343 pacientes incluidos en estudios clínicos y RETUD ✅118 ensayos clínicos/proyectos de investigación ✅134 publicaciones en revistas ✅269 comunicaciones a Congresos ✅11 ediciones becas y ayudas #SomosTTD ttdgroup.org/contenidos/con…

🧬Mismatch repair in pancreatic cancer JAMA Oncology ✅Although it is rare, MSI should be tested in pancreatic cancer ✅Median IO duration: 27.7 months, DCR: 80% 👉doi:10.1001/jamaoncol.2024.3651 Catherine O’Connor Emily Harrold Wungki Park, MD MS Eileen M O’Reilly #cancer #Oncology #MedX

Management of Locally Advanced Rectal Cancer: ASCO Guideline Clinical Insights 📌The article addresses the challenges clinicians may face in applying the ASCO guidelines for the management of locally advanced rectal cancer ascopubs.org/doi/10.1200/OP…

Frequency of HER2 alterations across tumor types & current development landscape of HER2-targeted therapies summarized in this publication. nature.com/articles/s4157…

🚨Drop the bolus | Omission of 5-Fluorouracil Bolus From Multidrug Regimens for Advanced Gastrointestinal Cancers: A Multicenter Cohort Study in: Journal of the National Comprehensive Cancer Network jnccn.org/view/journals/…

Pancreatic Cysts NEJM doi.org/10.1056/NEJMra… 👉once thought to be rare, now frequently found 👉Establishing cyst type is key 👏excellent comprehensive review on diagnostic & management ESMO - Eur. Oncology

Risk of bowel obstruction in patients with colon cancer responding to immunotherapy: an international case series - ESMO Open esmoopen.com/article/S2059-…

#ESMO24 ESMO - Eur. Oncology #Barcelona is less than a week away ⏰ Abstracts drop tomorrow! 👇resharing my list of #GIcancer abstracts to follow Looking forward to practice-changing data & connecting w/ colleagues 👋 OncoAlert OncologyEducation #CRCsm #HPBCsm #ESOCsm #STCsm #PancSM #ANCsm

Imágenes PET de cuerpo completo con Ac-Zr 89 de paciente con ca de páncreas. Se abre la puerta a estudios teragnosis (225Ac)👏👏👏